Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Phenylethylene Glycol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109628504A details a biphasic microbial resolution method. This technology enhances purity and yield for pharmaceutical intermediates while offering supply chain cost advantages.
Patent CN101302543A reveals a microbial method for high-purity (S)-phenylethylene glycol. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN101407780B details a novel site-directed mutagenesis method for producing high-purity (R)-phenylethylene glycol, offering significant cost and supply chain advantages.
Patent CN101613666B details a novel Bacillus sp. ECU0015 strain for high-purity chiral diol production, offering significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN104726355B reveals yeast spore technology for high-purity chiral intermediates with enhanced stability and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN101469318A enables high-purity (R)-phenylethylene glycol via dual-enzyme coupling, offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN104561136A enables high-yield chiral aryl ortho-diol production. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN101469318B details enzymatic synthesis achieving 100 percent e.e. purity. This report analyzes cost reduction in chiral chemical manufacturing and supply chain reliability for global buyers.
Patent CN104830704A details a recombinant Candida parapsilosis strain producing (R)-phenylethylene glycol with 99.9% ee. Offers cost reduction and supply reliability for pharma intermediates.
Patent CN104726355A details yeast spore biocatalysis for high-purity S-phenylethylene glycol. Offers cost reduction and supply reliability for pharmaceutical intermediates.
Patent CN101368168B enables high-purity chiral alcohol production via enzyme coupling. This method offers substantial cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN101230363B details a novel recombinant E. coli strain for asymmetric synthesis. This report analyzes cost reduction and supply chain advantages for pharmaceutical intermediates.
Patent CN104774778A details recombinant Candida parapsilosis for high-purity (S)-phenylethylene glycol. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel enzymatic coupling method for (S)-phenylethylene glycol production. Reduces coenzyme costs and improves supply chain reliability for pharmaceutical intermediates globally.
Patent CN104561136B enables high-yield chemo-enzymatic synthesis. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.